David M. Slovik, MD

David M. Slovik, MD, is an endocrinologist at Massachusetts General Hospital (MGH) who specializes in osteoporosis, and an associate professor of medicine at Harvard Medical School. He is currently chief of the division of endocrinology at Newton-Wellesley Hospital, and former chief of medicine at Spaulding Rehabilitation Hospital. Dr. Slovik did his internship in internal medicine at New York Hospital-Cornell Medical Center, and then went into the Indian Health Service for two years. He then came to Boston to complete his internal medicine residency and endocrine fellowship at MGH, and has remained on staff there in endocrine practice for over 40 years. Since 1991, Dr. Slovik has acted as the medical editor for Osteoporosis: A Guide to Prevention and Treatment, a Harvard Health Publishing Special Health Report.


Posts by David M. Slovik, MD

A new therapy for osteoporosis: Romosozumab

Osteoporosis affects 10 million people in the United States, the majority of them women. Romosozumab is a new type of medication for treating osteoporosis that offers another treatment option for some women after menopause.